MedTrace Logo

Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD Individuals

NCT05245890 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-02-18

No results posted yet for this study

Summary

Uric acid is the end product of dietary or endogenous purines degradation, and hyperuricemia is one of the most common metabolic disorders. A growing body of evidence, comprising a great deal of cross-sectional studies and several prospective ones, also indicates that hyperuricemia is associated with increased prevalence, incidence, and disease severity of non-alcoholic fatty liver disease (NAFLD).

Capitalizing on a cohort study in China, the investigators are aimed to assess the associations of SUA trajecteries with remission of NAFLD in NAFLD individuals and examined whether the association differs across subpopulations.

Conditions

  • Non-Alcoholic Fatty Liver Disease
  • Hyperuricemia

Sponsors & Collaborators

  • The First Afliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    collaborator UNKNOWN

  • Ningbo No. 1 Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-03-01
Completion
2024-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05245890 on ClinicalTrials.gov